Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 121 users online. 7 members and 114 guests.

Most users ever online was 3,930 at 07:07 PM on 04-20-2019.

8 results in 0.0208 seconds.
Keywords
Members
Tags
tests x
  •  

  • Federal Reserve Board announces Results from Second Round of Bank Stress Tests will be Released Friday, December 18, at 4:30 p.m. EST

    Federal Reserve Board announces Results from Second Round of Bank Stress Tests will be Released Friday, December 18, at 4:30 p.m. EST | site |


    (Information contained in Board of Governors of the Federal Reserve System press release: December 4, 2020) The Federal Reserve Board announced on Friday that results from its second round of bank stress tests will be released on Friday, December 18, at 4:30 p.m. EST. Stress tests help ensure that banks have adequate capital to absorb losses so that they can lend to households and businesses even in a severe recession. For this second round of stress tests, large banks will be tested against two scenarios, each featuring a severe recession to assess their resiliency. Earlier this year, the Board's first round of stress tests found that large banks were well capitalized. Nonetheless, in light of the economic uncertainty, the Board is conducting this second round to further test the resiliency of banks. Banks with mo...
    See more | Go to post

  • HHS Provides 25 Million Dollars to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests

    U.S. Department of Health and Human Services Provides $25 Million to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests | site |


    Dual Contracts Will Yield Two New Antigen Tests and Update Massachusetts Facility to Produce up to 50 Million Tests Per Month


    (Information contained in U.S. Department of Health and Human Services press release: November 19, 2020) Today, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DoD) awarded Siemens Healthineers a $12 million contract to support domestic production of two diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. The funding is in addition to a $13 million HHS contract awarded Nov. 2 to enable the company to develop the tests. Combined, the two contracts represent another $25 million investment by the federal government to expand the types of tests for COVID-19 and to ensure that sufficient numbers of tests are available ...
    See more | Go to post

  • HHS and DOD announce 12.7 Million Dollars Contract with InBios International to boost U.S. Production of Rapid COVID-19 Tests

    U.S. Department of Health and Human Services and U.S. Department of Defense announce $12.7 Million Contract with InBios International to boost U.S. Production of Rapid COVID-19 Tests | site |



    Number of diagnostic tests and antibody tests produced by Seattle company will expand by 20 times current capacity


    (October 31, 2020) - - The U.S. Department of Health and Human Services published today, October 31, 2020, the following information:

    Today, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DOD) jointly announced a $12.7 million contract with InBios International Inc., of Seattle, to expand domestic production capacity for two rapid point-of-care tests for SARS-CoV-2, the virus that causes COVID-19. The first, called the SCoV-2 Ag Detect Kit, detects current infections by identifying antigens – genetic material – of the virus in a nose swab sample. The second test...
    See more | Go to post

  • HHS says 389,000 BinaxNOW COVID-19 Tests Distributed Thus Far to Historically Black Colleges and Universities

    U.S. Department of Health and Human Services says 389,000 BinaxNOW COVID-19 Tests Distributed Thus Far to Historically Black Colleges and Universities (HBCU’s) | site |



    Top 10 State HBCU Distribution: NC, GA, LA, TX, AL, MD, MS, VA, SC, TN and FL


    (October 31, 2020) - - Today the U.S. Department of Health and Human Services published the following information:

    Washington, DC – As part of the Trump Administration’s ongoing national effort to prevent COVID-19 outbreaks in high risk communities, the U.S. Department of Health and Human Services (HHS) today detailed that 389,040 state-of-the-art Abbott BinaxNOW COVID-19 rapid tests have been distributed at no cost to 83 Historically Black Colleges and Universities (HCBU’s) in 24 states.

    Through the week of October 26, HBCU’s in North Carolina have been shipped 52,040 BinaxNOW tests – representing the highest state total; second is Georgia HCBU’s with 41,000; third is
    ...
    See more | Go to post

  • U.S. Food and Drug Administration Provides Promised Transparency for Coronavirus COVID-19 Antibody Tests

    U.S. Food and Drug Administration Provides Promised Transparency for Coronavirus COVID-19 Antibody Tests| site |



    (May 21, 2020) - - The U.S. Food and Drug Administration (FDA) published today (May 21, 2020) the following information:

    Today, the U.S. Food and Drug Administration posted a list of antibody tests that are being removed from the “notification list” of tests being offered under the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency. Antibody tests on this new removal list include those voluntarily withdrawn from the notification list by the test’s commercial manufacturer and those for which there is not a pending Emergency Use Authorization (EUA) request or issued EUA. FDA expects that the tests on the removal list will not be marketed or distributed. Antibody tests offered by commercial manufacturers as outlined under the policy, which was issued on March 16 and updated on May 4, continue to be located on
    ...
    See more | Go to post

  • U.S. Food and Drug Administration Expedites Review of Diagnostic Tests to Combat COVID-19

    U.S. Food and Drug Administration Expedites Review of Diagnostic Tests to Combat COVID-19 | site |




    (March 30, 2020) - - Today (March 30, 2020), the U.S. Food and Drug Administration (FDA) published the following information:



    March 30, 2020

    Statement From:

    Commissioner of Food and Drugs - Food and Drug Administration

    Stephen M. Hahn M.D.

    The U.S. Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the U.S. The FDA’s regulations have not hindered or been a roadblock to the rollout of tests during this pandemic. Every action the FDA has taken during this public health emergency to address the COVID-19 pandemic has balanced the urgent need to make diagnostic tests available with providing a level of oversight that ensures accurate tests are being deployed. Moreover, as in previous...
    See more | Go to post

  • U.S. Department of Health and Human Services Advances Development of Tests to Distinguish Bacterial from Viral Infections across Multiple Healthcare Settings

    U.S. Department of Health and Human Services Advances Development of Tests to Distinguish Bacterial from Viral Infections across Multiple Healthcare Settings| site |



    (November 14, 2019) - - Today, the U.S. Department of Health and Human Services published the following information:

    A novel diagnostics technology that reads gene expression patterns in the immune system to distinguish bacterial infections from viral infections and determines the severity within minutes will receive advanced development support from the U.S. Department of Health and Human Services (HHS). The technology is being designed for use in outpatient and inpatient healthcare settings.

    The Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), will support the advanced development of the new testing technology, known as host-response testing, under a 14-month, $6 million
    ...
    See more | Go to post

  • U.S. Food and Drug Administration Alerts Healthcare Providers and Women about Risks Associated with Improper Use of Rupture of Membranes Tests

    U.S. Food and Drug Administration Alerts Healthcare Providers and Women about Risks Associated with Improper Use of Rupture of Membranes Tests





    (August 8, 2018) - - The U.S. Food and Drug Administration today alerted women and their doctors about serious adverse events related to the improper use of tests intended as an aid in detecting if a pregnant woman’s water has broken (also known as a rupture of the membranes containing amniotic fluid). A rupture of the membranes (ROM) can pose immediate and severe risks to the patient and developing fetus without proper patient management and timely intervention.

    As part of the agency’s commitment to transparency in notifying the public about potential public health concerns, the FDA issued a Letter to Health Care Providers to remind providers that the labeling for these tests specifies that they should not be used on their
    ...
    See more | Go to post

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    Federal Reserve Board announces Results from Second Round of Bank Stress Tests will be Released Friday, December 18, at 4:30 p.m. EST
    by Staff Reporter 1
    Federal Reserve Board announces Results from Second Round of Bank Stress Tests will be Released Friday, December 18, at 4:30 p.m. EST | site |


    (Information contained in Board of Governors of the Federal Reserve System press release: December 4, 2020) The Federal Reserve Board announced on Friday that results from its second round of bank stress tests will be released on Friday, December 18, at 4:30 p.m. EST. Stress tests help ensure that banks have adequate capital to absorb losses so that they can lend to households and businesses even in a severe recession. For this second round of stress tests, large banks will be tested against two scenarios, each featuring a severe recession to assess their resiliency. Earlier this year, the Board's first round of stress tests found that large banks were well capitalized. Nonetheless, in light of the economic uncertainty, the Board is conducting this second round to further test the resiliency of banks. Banks with mo...
    12-04-2020, 08:33 PM
  • Staff Reporter 1
    HHS Provides 25 Million Dollars to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests
    by Staff Reporter 1
    U.S. Department of Health and Human Services Provides $25 Million to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests | site |


    Dual Contracts Will Yield Two New Antigen Tests and Update Massachusetts Facility to Produce up to 50 Million Tests Per Month


    (Information contained in U.S. Department of Health and Human Services press release: November 19, 2020) Today, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DoD) awarded Siemens Healthineers a $12 million contract to support domestic production of two diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. The funding is in addition to a $13 million HHS contract awarded Nov. 2 to enable the company to develop the tests. Combined, the two contracts represent another $25 million investment by the federal government to expand the types of tests for COVID-19 and to ensure that sufficient numbers of tests are available ...
    11-21-2020, 09:09 AM
  • Staff Reporter 1
    HHS and DOD announce 12.7 Million Dollars Contract with InBios International to boost U.S. Production of Rapid COVID-19 Tests
    by Staff Reporter 1
    U.S. Department of Health and Human Services and U.S. Department of Defense announce $12.7 Million Contract with InBios International to boost U.S. Production of Rapid COVID-19 Tests | site |



    Number of diagnostic tests and antibody tests produced by Seattle company will expand by 20 times current capacity


    (October 31, 2020) - - The U.S. Department of Health and Human Services published today, October 31, 2020, the following information:

    Today, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DOD) jointly announced a $12.7 million contract with InBios International Inc., of Seattle, to expand domestic production capacity for two rapid point-of-care tests for SARS-CoV-2, the virus that causes COVID-19. The first, called the SCoV-2 Ag Detect Kit, detects current infections by identifying antigens – genetic material – of the virus in a nose swab sample. The second test...
    11-05-2020, 04:05 PM
  • Staff Reporter 1
    HHS says 389,000 BinaxNOW COVID-19 Tests Distributed Thus Far to Historically Black Colleges and Universities
    by Staff Reporter 1
    U.S. Department of Health and Human Services says 389,000 BinaxNOW COVID-19 Tests Distributed Thus Far to Historically Black Colleges and Universities (HBCU’s) | site |



    Top 10 State HBCU Distribution: NC, GA, LA, TX, AL, MD, MS, VA, SC, TN and FL


    (October 31, 2020) - - Today the U.S. Department of Health and Human Services published the following information:

    Washington, DC – As part of the Trump Administration’s ongoing national effort to prevent COVID-19 outbreaks in high risk communities, the U.S. Department of Health and Human Services (HHS) today detailed that 389,040 state-of-the-art Abbott BinaxNOW COVID-19 rapid tests have been distributed at no cost to 83 Historically Black Colleges and Universities (HCBU’s) in 24 states.

    Through the week of October 26, HBCU’s in North Carolina have been shipped 52,040 BinaxNOW tests – representing the highest state total; second is Georgia HCBU’s with 41,000; third is
    ...
    11-01-2020, 04:42 AM
  • Staff Reporter 1
    U.S. Food and Drug Administration Provides Promised Transparency for Coronavirus COVID-19 Antibody Tests
    by Staff Reporter 1
    U.S. Food and Drug Administration Provides Promised Transparency for Coronavirus COVID-19 Antibody Tests| site |



    (May 21, 2020) - - The U.S. Food and Drug Administration (FDA) published today (May 21, 2020) the following information:

    Today, the U.S. Food and Drug Administration posted a list of antibody tests that are being removed from the “notification list” of tests being offered under the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency. Antibody tests on this new removal list include those voluntarily withdrawn from the notification list by the test’s commercial manufacturer and those for which there is not a pending Emergency Use Authorization (EUA) request or issued EUA. FDA expects that the tests on the removal list will not be marketed or distributed. Antibody tests offered by commercial manufacturers as outlined under the policy, which was issued on March 16 and updated on May 4, continue to be located on
    ...
    05-26-2020, 06:09 AM

Menu

Collapse

Menu

Collapse

Working...
X